Replies to post #23479 on Savvy Trades and Investments

[CPTMatt]

COV.V/CVALF Yes significant win. Worth doubling the share price? Not sure. I'm out for now and looking to get back in on a dip. The contract revs won't be included in current quarter and Medline might take some time to fully impact, remains to be seen. Could be another quarterly dissapointment on horizon which woukd be a nice buying opp.

I wouldn't trust any non-public rumor info.